The installation is part of Nebraska Medicine’s efforts to offer advanced cancer treatment options in a single location. Credit: Ronan Enright Solicitors / Pixabay.

Mevion Medical Systems has partnered with Nebraska Medicine to install a proton therapy system at the Fred & Pamela Buffett Cancer Center in Omaha, Nebraska, US.

The MEVION S250-FIT proton therapy system will be incorporated into an existing treatment room within the cancer centre’s radiation oncology department.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The cancer centre is among the first to adopt the MEVION S250-FIT technology alongside other healthcare providers such as BayCare, Stanford Health Care and Atlantic Health.

Its installation of the proton therapy system is part of Nebraska Medicine’s efforts to offer advanced cancer treatment options in a single, accessible location.

Nebraska Medicine CEO and board chair Dr James Linder said: “Nebraska Medicine is committed to providing our patients with the most advanced cancer care available.

“The support of the donor community has enabled the addition of proton therapy to the Fred & Pamela Buffett Cancer Center, and marks another important step in fulfilling that commitment.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Mevion Medical Systems president and CEO Tina Yu said: “We are excited to partner with Nebraska Medicine to make proton therapy more accessible to their patients.

“The MEVION S250-FIT represents a major advancement in proton therapy accessibility and affordability, and we are proud to collaborate with Nebraska Medicine in their mission to provide world-class treatment options.”

The MEVION S250-FIT system’s compact size, precise pencil beam scanning and upright patient positioning are expected to ‘revolutionise’ cancer care at the institution.

Its precision could be particularly useful for treating paediatric patients and targeting tumours in sensitive areas, as it offers the potential to reduce damage to healthy surrounding tissue.

Fred & Pamela Buffett Cancer Center director Dr Joann Sweasy said: “This advanced proton therapy system opens doors for us to explore new frontiers in cancer treatment, including FLASH therapy and other innovative approaches.

“We are committed to pushing the boundaries of proton therapy research and bringing the latest advancements to the clinic.”